GlassScriptPhysician profile
Glenn W Mclaughlin
NPI 1447289970
$7,916.81
in general payments reported to CMS, 2019-2025
11 companies · $18.70 in 2025
The $18.70 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $42.15 · 2021: $3,844 · 2022: $3,832 · 2024: $14.83 · 2025: $18.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $5,730.49 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $1,960.56 | 2021 | |
| Glaxosmithkline, LLC. | $46.02 | 2019 | |
| Amgen INC. | $45.78 | 2019 | |
| Astellas Pharma US INC | $30.78 | 2019 | |
| Sanofi Pasteur INC. | $30.29 | 2019-2020 | |
| Biogen, INC. | $18.70 | 2025 | Zurzuvae |
| Janssen Pharmaceuticals, INC | $14.97 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.50 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.88 | 2019 | |
| Lilly USA, LLC | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.